Acebo P et al. Cancer Abolishes the Tissue Type–Specific Differences in the Phenotype of Energetic Metabolism. Translational Oncology (September 2009) vol.2 no.3 pp.138–145.
Santamaria G et al. Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase. Carcinogenesis (2006) vol. 27 no.5 pp. 925-935
Cuezva JM et al. The bioenergetic signature of lung adenocarcinomas is a molecular marker of a cancer diagnosis and prognosis. Carcinogenesis (2004) vol.25 no.7 pp.1157-1163.
Isidoro A et al. Breast carcinomas fulill the Warburg hypothesis and provide metabolic marker of cancer prognosis. Carcinogenesis (2005) vol.26 no.12 pp.2095-2104.
Isidoro A et al. Alteration of the bioenergetic phenotype of mitochondria is a hallamark of breast, gastric, lung and oesophageal cancer. Biochem. J. (2004) 378, 17-20.
Cuezva JM et al. The Bioenergetic Signature of Cancer: A Marker of Tumor Progression. Cancer research (2002) 62, 6674-6681.
López Ríos F et al. Loss of the Mitochondrial Bioenergetic Capacity Underlies the glucose avidity of Carcinomas. Cancer research (2007); 67:(19).